Evaluation of bone turnover in postmenopause, vertebral fracture, and hip fracture using biochemical markers for bone formation and resorption

Journal of Endocrinological Investigation

Volumn 20, Issue 3, 1997, Pages 112-117

  Takahashi, M ^a   Kushida, K ^a   Hoshino, H ^a   Ohishi, T ^a   Inoue, T ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bone metabolism; ICTP; NTx; Osteocalcin; PICP; Pyridinoline

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; DEOXYPYRIDINOLINE; OSTEOCALCIN; PYRIDINOLINE;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE METABOLISM; BONE TURNOVER; CONTROLLED STUDY; FEMALE; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; POSTMENOPAUSE; VERTEBRA FRACTURE;

EID: 0030945860     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03346887     Document Type: Article

References (16)

1. Lian J.B., Gundberg C.M. Osteocalcin biochemical considerations and clinical applications. Clin. Orthop. 226: 267, 1988.
2. Parfitt A.M., Simon L.S., Villanueva A.R., Simon S.M. Procollagen type I carboxyterminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with iliac bone formation rates and comparison with total alkaline phosphatase. J. Bone Miner. Res. 2: 427, 1987.
3. Editorial Pyridinium crosslinks as markers of bone resorption. Lancet 2: 278, 1992.
4. Eyre D.R. Collagen cross-linking amino acids. Methods enzymol. 144: 115, 1987.
5. Robins S.P., Woitge H., Hesley R., Ju J., Seyedin S., Seibel M.J. Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption. J. Bone Miner. Res. 9: 1643, 1994.
6. Hanson D.A., Weis M.A.E., Bollen A.M., Maslan S.L., Singer F.R., Eyre D.R. A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urine. J. Bone Miner. Res. 7: 1251, 1992.
7. Eriksen E.F., Charles P., Melsen F., Mosekilde L., Risteli L., Risteli J. Serum markers of type I collagen formation and degradation in metabolic bone disease: Correlation with bone histomorphometry. J. Bone Miner. Res. 8: 127, 1993.
8. Kushida K., Takahashi M., Kawana K., Inoue T. Comparison of markers for bone formation and resorption in premenopausal and postmenopausal subjects, and osteoporosis patients. J. Clin. Endocrinol. Metab. 80: 2447, 1995.
9. Masters P.W., Jones R.G., Purves D.A., Cooper E.H. Cooney J.M. Commercial assays for serum osteocalcin give clinically discordant results. Clin. Chem. 40: 358, 1994.
10. Takahashi M., Ohishi T., Aoshima H., Kushida K., Inoue T., Horiuchi K. Pre-fractionation with cation exchanger for determination of intermolecular crosslinks, pyridinoline and pentosidine, in hydrolysate. J. Liq. Chromatogr. 16: 1355, 1993.
11. Kasai R., Bianco P., Robey P.G., Kahn A.J. Production and characterization of an antibody against the human bone GLA protein (BGP/osteocalcin) propeptide and its use in immunocytochemistry of bone cells. Bone and Miner. 25: 167, 1994.
12. Garnero P., Gineyts E., Arbault P., Christiansen C., Delmas P.D. Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion. J. Bone Miner. Res. 10: 641, 1995.
13. Åkesson K., Vergnaud P., Gineyts E., Delmas P.D., Obrant K.J. Impairment of bone turnover in elderly women with hip fracture. Calcif. Tissue Int. 53: 162, 1993.
14. Chevalley T., Rizzoli R., Nydegger V., Slosman D., Rapin C.H., Michel J.P., Vasey H., Bonjour J.P. Effects of calcium supplements on femoral bone mineral density and vertebral fracture rate in vitamine-D-replete elderly patients. Osteoporosis Int. 4: 245, 1994.
15. Cheung C.K., Panesar N.S., Lau E., Woo J., Swaminathan R. Increased bone resorption and decreased bone formation in Chinese patients with hip fracture. Calcif. Tissue Int. 56: 347, 1995.
16. Eastell R., Robins S.P., Colwell T., Assiri A.M.A., Riggs B.L., Russell R.G.G. Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption. Osteoporosis Int. 3: 255, 1993.